Korean J healthc assoc Infect Control Prev.  2019 Dec;24(2):108-111. 10.14192/kjicp.2019.24.2.108.

Excrement Strikes Back: The Dark Side of Fecal Microbiota Transplantation

• Kleven M

• KMID: 2467911
• DOI: http://doi.org/10.14192/kjicp.2019.24.2.108

Abstract

No abstract available.

MeSH Terms

Fecal Microbiota Transplantation*
Strikes, Employee*

Reference

1. Ghione S, Sarter H, Fumery M, Armengol-Debeir L, Savoye G, Ley D, et al. ; Epimad Group. Dramatic increase in incidence of ulcerative colitis and Crohn's disease (1988–2011): a population-based study of French adolescents. Am J Gastroenterol. 2018; 113:265–272.

2. Sýkora J, Pomahačová R, Kreslová M, Cvalínová D, Štych P, Schwarz J. Current global trends in the incidence of pediatric-onset inflammatory bowel disease. World J Gastroenterol. 2018; 24:2741–2763.

3. Karadsheh Z. Fecal transplantation for the treatment of recurrent Clostridium difficile infection. N Am J Med Sci. 2013; 5:339–343.

4. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med. 2000; 342:390–397.

5. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet. 2013; 45:109–113.

6. Burke KE. Clostridium difficile infection: a worldwide disease. Gut Liver. 2014; 8:1–6.

7. Lewis BB, Buffie CG, Carter RA, Leiner I, Toussaint NC, Miller LC, et al. Loss of microbiota-mediated colonization resistance to Clostridium difficile infection with oral vancomycin compared with metronidazole. J Infect Dis. 2015; 212:1656–1665.

8. Kassam Z, Hundal R, Marshall JK, Lee CH. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Arch Intern Med. 2012; 172:191–193.

9. Wang S, Xu M, Wang W, Cao X, Piao M, Khan S, et al. Systematic review: adverse events of fecal microbiota transplantation. PLoS One. 2016; 11:e0161174.

10. MacConnachie AA, Fox R, Kennedy DR, Seaton RA. Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. QJM. 2009; 102:781–784.

11. Pierog A, Mencin A, Reilly NR. Fecal microbiota transplantation in children with recurrent Clostridium difficile infection. Pediatr Infect Dis J. 2014; 33:1198–1200.

12. Silverman MS, Davis I, Pillai DR. Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clin Gastroenterol Hepatol. 2010; 8:471–473.

13. Schwartz M, Gluck M, Koon S. Norovirus gastroenteritis after fecal microbiota transplantation for treatment of Clostridium difficile infection despite asymptomatic donors and lack of sick contacts. Am J Gastroenterol. 2013; 108:1367.

14. Kelly CR, Khoruts A, Staley C, Sadowsky MJ, Abd M, Alani M, et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial. Ann Intern Med. 2016; 165:609–616.

15. De Leon LM, Watson JB, Kelly CR. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2013; 11:1036–1038.

16. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003; 36:580–585.

17. Administration-USFDA. Important safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse reactions due to transmission of multi-drug resistant organisms. U.S. Food & Drug;Updated on 13 Jun 2019. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/important-safety-alert-regarding-use-fecal-microbiota-transplantation-and-risk-serious-adverse.

18. Grady D. Fecal transplant is linked to a Patient's death, the F.D.A. warns. The New York Times;Updated on 13 Jun 2019. https://www.nytimes.com/2019/06/13/health/fecal-transplant-fda.html.

19. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007; 449:804–810.

20. Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007; 449:811–818.

21. Tremaroli V. Functional interactions between the gut microbiota and host metabolism. Nature. 2012; 489:242–249.

22. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature. 2011; 474:327–336.

23. Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015; 26:26191.

24. Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958; 44:854–859.

25. National Institute of Health. Clinical trial testing fecal microbiota transplant for recurrent diarrheal disease begins. Updated on 14 Jan 2019. https://www.nih.gov/news-events/news-releases/clinical-trial-testing-fecal-microbiota-transplant-recurrent-diarrheal-disease-begins.